Younes M - Search Results

1

The significance of "indefinite for dysplasia" grading in Barrett metaplasia.

Younes M, Lauwers GY, Ertan A, Ergun G, Verm R, Bridges M, Woods K, Meriano F, Schmulen C, Johnson C, Barroso A, Schwartz J, McKechnie J, Lechago J. Younes M, et al. Arch Pathol Lab Med. 2011 Apr;135(4):430-2. doi: 10.5858/2010-0097-OA.1. Arch Pathol Lab Med. 2011. PMID: 21466357 Free article.

2

Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia.

Younes M, Ertan A, Ergun G, Verm R, Bridges M, Woods K, Meriano F, Schmulen AC, Colman R, Johnson C, Barroso A, Schwartz J, McKechnie J, Lechago J. Younes M, et al. Arch Pathol Lab Med. 2007 Apr;131(4):571-5. doi: 10.5858/2007-131-571-GCMIEB. Arch Pathol Lab Med. 2007. PMID: 17425386 Free article.

3

p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients.

Younes M, Brown K, Lauwers GY, Ergun G, Meriano F, Schmulen AC, Barroso A, Ertan A. Younes M, et al. Histopathology. 2017 Jul;71(1):27-33. doi: 10.1111/his.13193. Epub 2017 Apr 11. Histopathology. 2017. PMID: 28226185 Free PMC article.

4

Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus.

Akgun H, Lechago J, Younes M. Akgun H, et al. Among authors: younes m. Anticancer Res. 2002 May-Jun;22(3):1459-61. Anticancer Res. 2002. PMID: 12168823

5

Expression of the high mobility group proteins HMGI(Y) correlates with malignant progression in Barrett's metaplasia.

Chen X, Lechago J, Ertan A, Ergun G, Verm R, Bridges M, Johnson C, Woods K, Meriano F, Chirala M, Younes M. Chen X, et al. Among authors: younes m. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):30-3. doi: 10.1158/1055-9965.epi-03-0151. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744729

6

p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study.

Younes M, Lebovitz RM, Lechago LV, Lechago J. Younes M, et al. Gastroenterology. 1993 Dec;105(6):1637-42. doi: 10.1016/0016-5085(93)91058-p. Gastroenterology. 1993. PMID: 8253340

7

p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia.

Younes M, Ertan A, Lechago LV, Somoano JR, Lechago J. Younes M, et al. Dig Dis Sci. 1997 Apr;42(4):697-701. doi: 10.1023/a:1018828207371. Dig Dis Sci. 1997. PMID: 9125634

8

Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia.

Younes M, Ertan A, Lechago LV, Somoano J, Lechago J. Younes M, et al. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):303-5. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9149888

9

Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia.

Younes M, Lechago J, Chakraborty S, Ostrowski M, Bridges M, Meriano F, Solcher D, Barroso A, Whitman D, Schwartz J, Johnson C, Schmulen AC, Verm R, Balsaver A, Carlson N, Ertant A. Younes M, et al. Scand J Gastroenterol. 2000 Feb;35(2):131-7. doi: 10.1080/003655200750024281. Scand J Gastroenterol. 2000. PMID: 10720109

10

Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus.

Younes M, Lechago J, Ertan A, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Hum Pathol. 2000 Apr;31(4):434-8. doi: 10.1053/hp.2000.6715. Hum Pathol. 2000. PMID: 10821489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

892 results

Search Page

Filters